90 related articles for article (PubMed ID: 12591077)
1. Problems with NASH? HAIR is some help.
Phillips H; Balart LA
Am J Gastroenterol; 2003 Feb; 98(2):500. PubMed ID: 12591077
[No Abstract] [Full Text] [Related]
2. Nonalcoholic fatty liver disease: defining a common problem.
Gasbarrini G; Vero V; Miele L; Forgione A; Hernandez AP; Greco AV; Gasbarrini A; Grieco A
Eur Rev Med Pharmacol Sci; 2005; 9(5):253-9. PubMed ID: 16231586
[TBL] [Abstract][Full Text] [Related]
3. Nonalcoholic fatty liver disease in severely obese subjects.
Gholam PM; Flancbaum L; Machan JT; Charney DA; Kotler DP
Am J Gastroenterol; 2007 Feb; 102(2):399-408. PubMed ID: 17311652
[TBL] [Abstract][Full Text] [Related]
4. Use of insulin sensitizers in NASH.
Khashab M; Chalasani N
Endocrinol Metab Clin North Am; 2007 Dec; 36(4):1067-87; xi. PubMed ID: 17983937
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity].
Chavarría-Arciniega S; López-Alvarenga JC; Uribe-Uribe NO; Herrera-Hernández M; González-Barranco J
Rev Invest Clin; 2005; 57(4):505-12. PubMed ID: 16315634
[TBL] [Abstract][Full Text] [Related]
6. Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors.
St George A; Bauman A; Johnston A; Farrell G; Chey T; George J
J Gastroenterol Hepatol; 2009 Mar; 24(3):399-407. PubMed ID: 19067776
[TBL] [Abstract][Full Text] [Related]
7. [On the clinical picture of fatty degeneration of the liver and fatty liver].
Teichmann W; Lindemann A
Z Gesamte Inn Med; 1967 Sep; 22(17):509-14. PubMed ID: 5591413
[No Abstract] [Full Text] [Related]
8. [Non-alcoholic fatty liver disease--new view].
Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
[TBL] [Abstract][Full Text] [Related]
9. Hypertension and fatty liver: guilty by association?
Brookes MJ; Cooper BT
J Hum Hypertens; 2007 Apr; 21(4):264-70. PubMed ID: 17273155
[TBL] [Abstract][Full Text] [Related]
10. Invasive and non-invasive investigations for non-alcoholic steatohepatitis (NASH): the need for biochemical markers.
Ahmed MH
Scand J Gastroenterol; 2006 Mar; 41(3):372. PubMed ID: 16497631
[No Abstract] [Full Text] [Related]
11. Evaluation and management of obesity-related nonalcoholic fatty liver disease.
Nugent C; Younossi ZM
Nat Clin Pract Gastroenterol Hepatol; 2007 Aug; 4(8):432-41. PubMed ID: 17667992
[TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.
Marchesini G; Bugianesi E; Forlani G; Cerrelli F; Lenzi M; Manini R; Natale S; Vanni E; Villanova N; Melchionda N; Rizzetto M
Hepatology; 2003 Apr; 37(4):917-23. PubMed ID: 12668987
[TBL] [Abstract][Full Text] [Related]
13. Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass.
Boza C; Riquelme A; Ibañez L; Duarte I; Norero E; Viviani P; Soza A; Fernandez JI; Raddatz A; Guzman S; Arrese M
Obes Surg; 2005 Sep; 15(8):1148-53. PubMed ID: 16197788
[TBL] [Abstract][Full Text] [Related]
14. Predictive factors for pure steatosis in alcoholic patients.
Naveau S; Thaury J; Barri-Ova N; Balian A; Dauvois B; Njiké-Nakseu M; Prévot S; Agostini H; Perlemuter G
Alcohol Clin Exp Res; 2009 Jun; 33(6):1104-10. PubMed ID: 19382900
[TBL] [Abstract][Full Text] [Related]
15. Significant non-alcoholic fatty liver disease is found in non-diabetic, pre-obese Chinese in Singapore.
Chow WC; Tai ES; Lian SC; Tan CK; Sng I; Ng HS
Singapore Med J; 2007 Aug; 48(8):752-7. PubMed ID: 17657385
[TBL] [Abstract][Full Text] [Related]
16. Nonalcoholic fatty liver disease.
Bayard M; Holt J; Boroughs E
Am Fam Physician; 2006 Jun; 73(11):1961-8. PubMed ID: 16770927
[TBL] [Abstract][Full Text] [Related]
17. Body mass index and waist circumference in non-alcoholic fatty liver disease.
Rocha R; Cotrim HP; Carvalho FM; Siqueira AC; Braga H; Freitas LA
J Hum Nutr Diet; 2005 Oct; 18(5):365-70. PubMed ID: 16150132
[TBL] [Abstract][Full Text] [Related]
18. Differentiating between benign and non-benign obesity: look at the liver.
Poupon R
Gastroenterol Clin Biol; 2010; 34(4-5):244-5. PubMed ID: 20456887
[TBL] [Abstract][Full Text] [Related]
19. Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-gamma ligand rosiglitazone.
Neuschwander-Tetri BA; Brunt EM; Wehmeier KR; Oliver D; Bacon BR
Hepatology; 2003 Oct; 38(4):1008-17. PubMed ID: 14512888
[TBL] [Abstract][Full Text] [Related]
20. Nonalcoholic fatty liver disease: hepatic manifestation of obesity and the metabolic syndrome.
Boppidi H; Daram SR
Postgrad Med; 2008 Jul; 120(2):E01-7. PubMed ID: 18654060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
